Dmytro Kharkov

Barostim adoption in heart failure management advances, led by CVRx

Barostim adoption in heart failure management advances, led by CVRx
CVRx spotlights Barostim integration

CVRx will address the integration of Barostim technology into heart failure care at the upcoming American Association of Heart Failure Nurses (AAHFN) Annual Meeting.

The session will feature expert faculty sharing practical insights on patient identification and selection, as well as collaboration between physicians and advanced practice providers. Through real-world case discussions, attendees can expect actionable guidance to enhance clinical outcomes with Barostim therapies.

CVRx recently marked a milestone with the first Barostim implant at Huntsville Hospital, expanding device therapy options for heart failure patients, according to a company announcement. Access to Barostim therapy has also grown through a partnership with RWJBarnabas Health at Robert Wood Johnson University Hospital, as reported in previous coverage. These collaborations reflect ongoing efforts to broaden availability of Barostim technology in clinical settings.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.